ObsEva SA Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Loumaye Ernest, was filed 11 Apr 2023.
ObsEva SA: what insiders have been doing
Every trade that managers of ObsEva SA disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for ObsEva SA. The previous disclosure was published on 11 April 2023.
Looking back to 2023, when coverage begins, insiders filed 2 purchases and no sales.
In the same sector, recent insider purchases at Xenon Pharmaceuticals Inc. and Vivos Inc also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -94.6%Entry 0.09 · Close at T+365 0.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
- 4,000,000 shares@ US$0.09545.6% of flowCommon SharesSEC:0001209191-23-023988:0Canonical exit: 5 Jul 2023 (T+90)
- 4,000,000 shares@ US$0.1154.4% of flowCommon SharesSEC:0001209191-23-014638:0Canonical exit: 29 May 2023 (T+90)
2 of 2 declarations
About ObsEva SA
ObsEva SA is a biopharmaceutical company focused on developing treatments for reproductive disorders and women's health. It is listed on NASDAQ under the ticker OBSV.
